Conversely, in breast cancer, increased METTL3‐mediated m6A methylation has been associated with enhanced tumorigenicity, potentially through modulating the stability and translation of genes involved in cell cycle progression and metastasis [168]. The gene discussed is METTL3; the disease is breast carcinoma.